The neurobehavioural effects of kava

References

• Duffield A M, Jamieson D D. Chemistry and pharmacology of kava. Kava: use and abuse in Australia and the South Pacific, J Prescott, G McCall. National Drug and Alcohol Research Centre, Sydney 1988; 1–12, (Monograph no. 5)
   Google Scholar
• Pfeiffer C C, Murphree H B, Goldstein L. Effect of kava in normal subjects and patients. ethnopharmacological search for psychoactive drugs, D H Efron, B Holmstedt, N S Kline. Public Health Service Publication No 1645, Washington DC 1967; 155–161
   Google Scholar
• Shulgin A T. The narcotic pepper – the chemistry and pharmacology of piper methysticum and related species. Bulletin of Narcotics 1973; 25: 59–74
   Google Scholar
• Pittler M H, Ernst E. Efficiacy of kava extract for treating anxiety. systematic review and meta-analysis. Journal of Clinical Psychopharmacology 2000; 20: 84–89
   PubMed Web of Science ®Google Scholar
• Lebot V, Merlin M, Lindstrom L. Kava, the Pacific elixir: the definitive guide to its ethnobotany, history and chemistry2nd edn. Healing Arts Press, Rochester, Vermont 1997
   Google Scholar
• Cawte J. Parameters of kava used as a challenge to alcohol. Australian and New Zealand Journal of Psychiatry 1986; 20: 70–76
   PubMed Web of Science ®Google Scholar
• Singh Y N. Kava: an overview. Journal of Ethnopharmacology 1992; 37: 13–45
   PubMed Web of Science ®Google Scholar
• Naisilisili S. Social and behavioural issues related to kava consumption: a study of kava drinking in Fiji. Pacific Islands Nutrition 1999; 41: 11–12
   Google Scholar
• McDonald D, Jowitt A. Kava in the Pacific Islands. A contemporary drug of abuse?. Drug and Alcohol Review 2000; 19: 217–227
   Web of Science ®Google Scholar
• d'Abbs P. A review of kava control measures in the Northern Territory. Menzies School of Health Research, Darwin 1993
   Google Scholar
• Douglas W. The effects of heavy usage of kava on physical health [letter]. The Medical Journal of Australia 1988; 149: 341–342
   PubMed Web of Science ®Google Scholar
• Mathews J D, Riley M D, Fejo L, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. The Medical Journal of Australia 1988; 148: 548–555
   PubMed Web of Science ®Google Scholar
• Markowitz J S. Herbal medicines assuming larger role in psychiatric care. Drug Topics 1998; 142: 50–53
   Google Scholar
• Wong A HC, Smith M, Boon H S. Herbal remedies in psychiatric practice. Archives in General Psychiatry 1998; 55: 1033–1044
   PubMed Web of Science ®Google Scholar
• Zinberg N E. Drug, Set and Setting: the Basis for Controlled Intoxicant Use. Yale University Press, New Haven 1984
   Google Scholar
• Schultes R E, Hofmann A. Plants of the gods: their sacred, healing and hallucinogenic powers. Healing Arts Press, Rochester 1992
   Google Scholar
• Brunton R. Kava and the daily dissolution of society on Tanna, New Hebrides. Mankind 1979; 12: 93–103
   Google Scholar
• Turner J. The water of life: kava ritual and the logic of sacrifice. ethnology. 1986; 25: 203–214
   Google Scholar
• Turner J. Substance, symbol and practice: the power of kava in Fijian society. Canberra Anthropology 1995; 18: 97–118
   Google Scholar
• Gregory R J, Cawte J E. The principles of alien poisons. contrasting psychopharmacology of kava in Oceania and Australia. Kava: use and abuse in Australia and the South Pacific, J Prescott, G McCall. University of New South Wales, Sydney 1988; 29–39, (Monograph no. 5). 11-11-
   Google Scholar
• Sahlins M. How natives think about Captain Cook, for example. University of Chicago Press, Chicago 1995
   Google Scholar
• Dunlop I. We believe in it: we know it's true [videocassette]. Film Australia, Lindfield, NSW 1996
   Google Scholar
• Williams N. The Yolngu and their land: a system of land tenure and the fight for its recognition. Australian Institute of Aboriginal Studies, Canberra 1986
   Google Scholar
• Reid J. Sorcerers and Healing Spirits. Australian National University, Canberra 1983
   Google Scholar
• Cawte J. Healers of Arnhem Land. University of New South Wales, Sydney 1996
   Google Scholar
• Moyles W. Aboriginal community use of kava as an alcohol substitute. Aboriginal Training and Cultural Institute, Balmain 1982
   Google Scholar
• Ford C S. Ethnographical aspects of kava. ethnopharmacological search for psychoactive drugs, D H Efron, B Holmstedt, N S Kline. Public Health Service Publication No 1645, Washington DC 1967; 162–173
   Google Scholar
• Clough A R, Burns C B, Mununggurr N. Kava in Arnhem Land: a review of consumption and its social correlates. Drug and Alcohol Review 2000; 19: 319–328
   Web of Science ®Google Scholar
• Rotblatt M D. Medicine cabinets: cranberry, feverfew, horse chestnut, and kava. Western Journal of Medicine 1999; 171: 195–198
   PubMedGoogle Scholar
• Schelosky L, Raffauf C, Jendroska K, Poewe W. Kava and dopamine antagonism. Journal of Neurology, Neurosurgery and Psychiatry 1995; 58: 639–640
   PubMed Web of Science ®Google Scholar
• Brunton R. A harmless substance? Anthropological aspects of kava in the South Pacific. Kava: use and abuse in Australia and the South Pacific, J Prescott, G McCall. National Drug and Alcohol Research Centre, Sydney 1988; 13–25, (Monograph no. 5). 11-11-
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders3rd edn. American Psychiatric Association, Washington DC 1994
   Google Scholar
• Foo H, Lemon J. Acute effects of kava, alone or in combination with alcohol, on subjective measures of impairment and intoxication and on cognitive performance. Drug and Alcohol Review 1997; 16: 147–155
   PubMed Web of Science ®Google Scholar
• Almeida J A, Grimsley E. Coma from the health food store: interaction between kava and alprazolam. Annals of Internal Medicine 1996; 125: 940–941
   PubMed Web of Science ®Google Scholar
• Spillane P K, Fisher D A, Currie B J. Neurological manifestations of kava intoxication. The Medical Journal of Australia 1997; 167: 172–173
   PubMed Web of Science ®Google Scholar
• Klohs M W. Chemistry of kava. ethnopharmacological Search for Psychoactive Drugs, D H Efron, B Holmstedt, N S Kline. Public Health Service Publication No 1645, Washington DC 1967; 126–132
   Google Scholar
• Jamieson D D, Duffield P H, Cheng D, Duffield A M. Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch International Pharmacodyn 1989; 301: 66–80
   PubMedGoogle Scholar
• Meyer H J. Pharmacology of Kava. ethnopharmacological Search for Psychoactive Drugs, D H Efron, B Holmstedt, N S Kline. Public Health Service Publication No 1645, Washington DC 1967; 133–140
   Google Scholar
• Keledjian J, Duffield P H, Jamieson D D, Lidgard R O, Duffield A M. Uptake into mouse brain of four compounds present in the psychoactive beverage kava. Journal of Pharmaceutical Sciences 1988; 77: 1003–1006
   PubMed Web of Science ®Google Scholar
• Davies L P, Drew C A, Duffield P, Johnston G AR, Jamieson D D. Kava pyrones and resin: studies of GABAA, GABAB and benzodiazepine binding sites in rodent brain. Pharmacology & Toxicology 1992; 71: 120–126
   PubMedGoogle Scholar
• Walden J, Von Wegerer J, Winter U, Berger M. Actions of kavain and dihydromethysticin on ipsapirone-induced field potential changes in the hippocampus. Human Psychopharmacology 1997; 12: 265–270
   Web of Science ®Google Scholar
• Gleitz J, Friese J, Beile A, Ameri A, Peters T. Anticonvulsive action of (+/-) -kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. European Journal of Pharmacology 1996; 315: 89–97
   PubMed Web of Science ®Google Scholar
• Singh Y N. Effects of kava on neuromuscular transmission and muscle contractility. Journal of Ethnopharmacology 1983; 7: 267–276
   PubMed Web of Science ®Google Scholar
• Gleitz J, Beile A, Peters T. (+/-) -kavain inhibits veratridine-activated voltage-dependent Na+-channels in synaptosomes prepared from rat cerebral cortex. Neuropharmacology 1995; 34: 1133–1138
   PubMed Web of Science ®Google Scholar
• Magura E I, Kopanitsa M V, Gleitz J, Peters T, Krishtal O A. Kava extract ingredients, (+) -methysticin (±) -kavain inhibit voltageoperated Na+-channels in rat CA1 hippocampal neurons. Neuroscience 1997; 81: 345–351
   PubMed Web of Science ®Google Scholar
• Langosch J M, Normann C, Schirrmacher K, Berger M, Walden J. The influence of (±) -kavain on population spikes and long-term potentiation in guinea pig hippocampal slices. Comparative Biochemistry and Physiology Part A 1998; 120: 545–549
   PubMed Web of Science ®Google Scholar
• Seitz U, Schule A, Gleitz J. 3H-monoamine uptake inhibition properties of kava pyrones. Planta Medica 1997; 63: 548–549
   PubMed Web of Science ®Google Scholar
• Walden J, Von Wegerer J, Winter U, Berger M, Grunze H. Effects of kawain and dihydromethysticin on field potential charges in the hippocampus. Progress in NeuroPsychopharmacology & Biological Psychiatry 1997; 21: 697–706
   PubMed Web of Science ®Google Scholar
• Uebelhack R, Franke L, Schewe H J. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 1998; 31: 187–192
   PubMed Web of Science ®Google Scholar
• Schirrmacher K, Busselberg D, Langosch J M, Walden J, Winter U, Bingmann D. Effects of (+/-) -kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats. European Neuropsychopharmacology 1999; 9: 171–176
   PubMed Web of Science ®Google Scholar
• Gleitz J, Beile A, Peters T. (+/-) -kavain inhibits veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes. Neuropharmacology 1996; 35: 179–186
   PubMed Web of Science ®Google Scholar
• Duffield P H, Jamieson D D, Duffield A M. [Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats.]. Archives Internationales de Pharmacodynamie et de Therapie 1989; 301: 81–90, (In French.)
   PubMedGoogle Scholar
• Baum S S, Hill R, Rommelspacher H. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1998; 22: 1105–1120
   PubMed Web of Science ®Google Scholar
• Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 1994; 116: 469–474
   PubMed Web of Science ®Google Scholar
• Buckley J P, Furgiuele A R, O'Hara M J. Pharmacology of kava. ethnopharmacological search for psychoactive drugs, D H Efron, B Holmstedt, N S Kline. Public Health Service Publication No 1645, Washington DC 1967; 141–151
   Google Scholar
• Holm E, Staedt U, Heep J, et al. [The action profile of D, 1-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals]. Arzneimittel-Forschung 1991; 41: 673–683, [German].
   PubMed Web of Science ®Google Scholar
• Boonen G, Ferger B, Kuschinsky K, Haberlein H. In Vivo effects of the kavapyrones (+) -dihydromethysticin (+/-) -kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. Planta Medica 1998; 64: 507–510
   PubMed Web of Science ®Google Scholar
• Bliss T VP, Collingridge G L. A synaptic model of memory long-term potentiation in the hippocampus. Nature 1993; 361: 31–39
   PubMed Web of Science ®Google Scholar
• Russell P N, Bakker D, Singh N. The effects of kava on alerting and speed of access of information from long-term memory. Bulletin of the Psychonomic Society 1987; 25: 236–237
   Google Scholar
• Prescott J, Jamieson D, Emdur N, Duffield P. Acute effects of kava on measures of cognitive performance, physiological function and mood. Drug and Alcohol Review 1993; 12: 49–58
   PubMedGoogle Scholar
• Münte T F, Heinze H J, Matzke M, Steitz J. Effects of oxazepam and an extract of kava roots (piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 1993; 27: 46–53
   PubMed Web of Science ®Google Scholar
• Heinze H J, Münthe T F, Steitz J, Matzke M. Pharmacological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry 1994; 27: 224–230
   PubMed Web of Science ®Google Scholar
• Saletu B, Grünberger J, Linzmayer L, Anderer P. EEG-brain mapping, psychometric and psychophysiological studies on central effects of kavain – a kava plant derivative. Human Psychopharmacology 1989; 4: 169–190
   Google Scholar